SURF — Surface Oncology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall Cap

Annual balance sheet for Surface Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	159	105	175	154	125
Net Total Accounts Receivable
Net Total Receivables	1.25	0.336	2.57	0.765	0.197
Prepaid Expenses
Total Other Current Assets
Total Current Assets	165	108	181	157	129
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.23	22.1	34.6	31.5	29.2
Other Long Term Assets
Total Assets	174	132	217	191	160
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	27.2	19.3	17.7	20	16.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	71.2	75	61.4	71.9	66.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	103	56.7	156	119	93.4
Total Liabilities & Shareholders' Equity	174	132	217	191	160
Total Common Shares Outstanding